Advertisement

How McKesson's Mixed Q1 Results Still Beat Wall Street Estimates

How McKesson's Mixed Q1 Results Still Beat Wall Street Estimates

The big healthcare company faced COVID-19 headwinds. But its business improved more strongly than expected.